FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      
1. Name and Address of Reporting Person * Jacobs Joshua 2. Issuer Name and Ticker or Trading Symbol theMaven, Inc. [ MVEN ] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable)__X__ Director                    _____ 10% Owner
_____ Officer (give title below)    _____ Other (specify below)
(Last)         (First)         (Middle)
225 LIBERTY STREET, 27TH FLOOR
3. Date of Earliest Transaction (MM/DD/YYYY)
2/20/2018
(Street)
NEW YORK, NY 10281
(City)       (State)       (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)
 
6. Individual or Joint/Group Filing (Check Applicable Line) _X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock  2/6/2020    A    62500  A $0.00  87500  D   
Common Stock  1/1/2021    A    83333  A $0.00  170833  D   

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Options to purchase  $1.90  2/20/2018    A     200000      2/20/2019 (1) 2/20/2028  Common Stock  200000  $0.00  200000  D   
Options to purchase  $1.90  2/20/2018    A     400000      5/23/2019 (2) 2/20/2028  Common Stock  400000  $0.00  400000  D   
Convertible Debenture  $1.2912  6/15/2018    P     19362      6/15/2018  6/30/2019  Common Stock  19362  $25000  19362  D   
Convertible Debenture  $1.2912  8/6/2018    I        19362   6/15/2018  6/30/2019  Common Stock  19362  $25000  0  D   
Series H Convertible Preferred Stock  $0.33  8/6/2018    P     30      8/6/2018   (3) Common Stock  90909  $1000  90909  D   
Options to purchase  $0.5425  9/13/2018    A     1500000      10/14/2018  9/14/2028  Common Stock  1500000  $0.00  1500000  D   

Explanation of Responses:
(1)  Grant vests 1/3 after first year. Balance monthly over next 2 years
(2)  200,000 vest after 12 months (from 5/23/18). 16,667 vest monthly for next 12 months.
(3)  Not applicable

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Jacobs Joshua
225 LIBERTY STREET, 27TH FLOOR
NEW YORK, NY 10281
X



Signatures
/s/ Josh Jacobs 1/27/2021
**Signature of Reporting Person Date